Journal of Neuropsychiatry · 1994 · 83 citations · 13 references
MedicinePharmacotherapyPsychiatryClinical PharmacologyNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapySeizure ManagementAnticonvulsant DrugsAntipsychotic ActionAntipsychotic Medication UseAntipsychotic Side EffectsAtypical Antipsychotic TreatmentClinical Toxicity AssessmentClonic SeizuresSeizures
Clozapine, an atypical antipsychotic drug, is widely used in refractory schizophrenia. At New Hampshire Hospital, 7 of the first 35 patients treated (20%) had convulsions. Patterns were tonic-clonic (5), complex partial (2), and myoclonic (3). Seizures were dose-related and may be anticholinergic in etiology. EEG changes are frequent with clozapine, particularly as dosage is increased. Twenty-six of 35 patients (74%) had EEG abnormalities at some time during clozapine treatment. EEG is a sensitive means of detecting clinical toxicity. When EEG abnormalities (slowing, dysrhythmia, or paroxysmal discharges) are detected, immediately lowering the dose by at least 25-50 mg per day and adjusting weekly until EEG returns to baseline can reduce the incidence of seizures.
13
Clozapine for the Treatment-Resistant Schizophrenic
John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations
Medicine, Pharmacology, Psychiatry +16
Orrin Devinsky, Gilbert Honigfeld, John Patin · Neurology · 1991 · 323 citations
The Risks and Benefits of Clozapine versus Chlorpromazine
James L. Claghorn, Gilbert Honigfeld, F.S. Abuzzahab et al. · Journal of Clinical Psychopharmacology · 1987 · 304 citations
Tolerability and therapeutic effect of clozapine
Uffe Juul Povlsen, U. Norrng, R. Fog et al. · Acta Psychiatrica Scandinavica · 1985 · 280 citations